GSL

AIMT failed breakout after first IPO base pattern.

NASDAQ:AIMT   AIMMUNE THERAPEUTICS, INC. - COMMON STOCK
104 0 0
AIMT formed a classic cup-with-handle IPO base, and eclipsed its buy point at $26.08 on a huge spike in volume on September 30. The breakout failed the very next day. Still basing. A downside break of $18.47 (the Aug 24 low) would set up a larger double-bottom base.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out